Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation - Could it refine clinical risk stratification in AF?

International Journal of Cardiology

Volumn 170, Issue 3, 2014, Pages 344-349

  Chao, Tze Fan ^a,b   Liu, Chia Jen ^a,b   Chen, Su Jung ^a   Wang, Kang Ling ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Chen, Tzeng Ji ^a   Tsao, Hsuan Ming ^b   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; CHA2DS2 VASc score; Hyperuricemia; Stroke

Indexed keywords

ANTIGOUT AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GOUT; HEART ATRIUM FIBRILLATION; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TAIWAN;

ATRIAL FIBRILLATION; CHA(2)DS(2)-VASC SCORE; HYPERURICEMIA; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; TAIWAN;

EID: 84891017368     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.011     Document Type: Article

References (34)

1. T.S. Potpara, and G.Y. Lip Lone atrial fibrillation: what is known and what is to come Int J Clin Pract 65 2011 446 457
2. S.S. Chugh, J.L. Blackshear, W.K. Shen, S.C. Hammill, and B.J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J Am Coll Cardiol 37 2001 371 378
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
4. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
5. A.J. Camm, P. Kirchhof, and G.Y. Lip et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
6. A.J. Camm, G.Y. Lip, and R. De Caterina et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
7. J.B. Olesen, G.Y. Lip, and M.L. Hansen et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
8. T.F. Chao, Y.J. Lin, and H.M. Tsao et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation J Am Coll Cardiol 58 2011 2380 2385
9. T.S. Potpara, M.M. Polovina, M.M. Licina, J.M. Marinkovic, M.S. Prostran, and G.Y. Lip Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade Atrial Fibrillation Study Circ Arrhythm Electrophysiol 5 2012 319 326
10. 2 score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179
11. 2-VASc score of 0 or 1? Stroke 43 2012 2551 2555
12. Y. Zhu, B.J. Pandya, and H.K. Choi Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008 Arthritis Rheum 63 2011 3136 3141
13. S. Lehto, L. Niskanen, T. Ronnemaa, and M. Laakso Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus Stroke 29 1998 635 639
14. K.L. Chien, H.C. Hsu, F.C. Sung, T.C. Su, M.F. Chen, and Y.T. Lee Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort Study Atherosclerosis 183 2005 147 155
15. M.J. Bos, P.J. Koudstaal, A. Hofman, J.C. Witteman, and M.M. Breteler Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study Stroke 37 2006 1503 1507
16. A. Hozawa, A.R. Folsom, H. Ibrahim, F. Javier Nieto, W.D. Rosamond, and E. Shahar Serum uric acid and risk of ischemic stroke: the ARIC Study Atherosclerosis 187 2006 401 407
17. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and risk of stroke: a systematic review and meta-analysis Arthritis Rheum 61 2009 885 892
18. E. von Elm, D.G. Altman, and M. Egger et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ 335 2007 806 808
19. C. Ruggiero, A. Cherubini, and A. Ble et al. Uric acid and inflammatory markers Eur Heart J 27 2006 1174 1181
20. E. Krishnan, B.J. Pandya, L. Chung, A. Hariri, and O. Dabbous Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study Am J Epidemiol 176 2012 108 116
21. I. Papezikova, M. Pekarova, and H. Kolarova et al. Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production Free Radic Res 47 2013 82 88
22. S.H. Heo, and S.H. Lee High levels of serum uric acid are associated with silent brain infarction J Neurol Sci 297 2010 6 10
23. N. Ishizaka, Y. Ishizaka, E. Toda, R. Nagai, and M. Yamakado Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals Arterioscler Thromb Vasc Biol 25 2005 1038 1044
24. N. Ishizaka, Y. Ishizaka, E. Toda, H. Hashimoto, R. Nagai, and M. Yamakado Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals Atherosclerosis 192 2007 131 137
25. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
26. G.Y. Lip, and J.L. Halperin Improving stroke risk stratification in atrial fibrillation Am J Med 123 2010 484 488
27. G.Y. Lip Stroke in atrial fibrillation: epidemiology and thromboprophylaxis J Thromb Haemost 9 Suppl. 1 2011 344 351
28. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y. Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
29. E. Abu-Assi, F. Otero-Ravina, and G. Allut Vidal et al. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation Int J Cardiol 166 2013 205 209
30. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
31. M.R. Patel, K.W. Mahaffey, and J. Garg et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
32. C.B. Granger, J.H. Alexander, and J.J. McMurray et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
33. R.G. Hart, L.A. Pearce, R.M. Rothbart, J.H. McAnulty, R.W. Asinger, and J.L. Halperin Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Prevention in Atrial Fibrillation Investigators Stroke J Am Coll Cardiol 35 2000 183 187
34. S.H. Hohnloser, D. Pajitnev, and J. Pogue et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy J Am Coll Cardiol 50 2007 2156 2161